- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03986047
Effect of Thermal Therapy and Exercises on Acute Low Back Pain
Effect of Thermal Therapy in Combination With Exercises to Relieve Acute Low Back Pain
Low back pain (LBP) ranks among the first diseases in term of years lived with disability. The latest Clinical Guideline from the American College of Physicians for acute LBP recommends to select "nonpharmacologic treatment with superficial heat, massage, acupuncture or spinal manipulation". The application of superficial heat ("thermal therapy") may provide enough pain relief in the acute phase to remain active, which is recommended to prevent the development of chronicity. However, no studies have tested if the combination of heat and exercises provide additional benefit on short, middle and long-term follow-up in people with acute LBP.
Hence, the main objective of this study is to determine the immediate, short-, middle- and long-term effect of continuous low-level thermal therapy in combination or not with exercises on pain, disability, and physical activity level in people with acute LBP.
Project hypothesis : The Thermal care + Exercises group will show greater improvement in pain, disability and physical activity level than both Thermal care and Control groups for immediate, short-, middle- and long-term follow-ups.
Sixty individuals with acute LBP will be recruited. This study will include six assessments over 6 months. At the baseline evaluation, participants will complete questionnaires on symptoms, disability, pain-related fear and self-efficacy. Afterwards, participants will be randomly assigned to one of three intervention programs: 1) Thermal care group, 2) Exercises + Thermal care group, and 3) Control group. They will immediately meet a physical therapist to review and perform their assigned program.
Participants will then take part in their assigned 7-day intervention program, during which they will wear a fitness wristband to track physical activity level. Finally, the same outcomes will be reassessed to determine the effect of intervention at 1 week, 1 month, 3 months and 6 months after baseline.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Low back pain (LBP) ranks among the first diseases in term of years lived with disability, which is mostly explained by the development of recurrent or chronic pain. A systematic review observed that 62% of patients still have pain 12 months after onset (recurrent and chronic) while another estimated that between 2% and 34% of acute cases will develop chronic LBP. These rates highlight the need to identify the best therapeutic approaches at the acute stage to prevent transition to chronicity and high recurrence. The latest Clinical Guideline from the American College of Physicians for acute LBP recommends to select "nonpharmacologic treatment with superficial heat, massage, acupuncture or spinal manipulation". The application of superficial heat ("thermal therapy") presented the strongest evidence (moderate) for short-term reduction in pain. Four randomized controlled trials (RCT) that tested the effect of a wearable heatwrap (the most studied form of thermal therapy in acute LBP) reported a reduction in pain and disability up to 2 days after cessation of the intervention: an effect superior to Ibuprofen, Acetaminophen or oral placebo. Heatwrap may provide enough pain relief in the acute phase to remain active, which is recommended to prevent the development of chronicity. One RCT showed that the addition of a heatwrap to exercise provided greater short-term improvement in pain/disability than exercise alone. Although some authors suggest that an increase in physical activity level may explain such an effect, this assumption has not been tested yet.
Hence, the main objective of this RCT is to determine the immediate, short-, middle- and long-term effect of continuous low-level thermal therapy in combination or not with exercises on pain, disability, and physical activity level in people with acute LBP.
Project hypothesis : The Thermal care + Exercises group will show greater improvement in pain, disability and physical activity level than both Thermal care and Control groups for immediate, short-, middle- and long-term follow-ups.
Participants: Individuals with acute LBP will be included according to the mentioned inclusion/exclusion criteria. They will be recruited from medical and through the electronic mailing list of Université Laval (> 52,000 individuals). The list of participants of the Quebec Low Back Pain Study (QLBPS Core Dataset, funded by the QPRN) will also be used - all participants in the Quebec City area recruited for the QLBPS Core Dataset will be referred for the present project.
Study Design: This study will include six assessments over 6 months : baseline pre, 1-hour post, 1 week, 1 month, 3 months, 6 months. At the baseline evaluation (baseline pre), participants will complete self-administered questionnaires on symptoms and disability (Numerical scale for pain, Oswestry Disability Index - ODI, Global Rating of Change - GRC), on pain-related fear (Tampa Scale of Kinesiophobia - TSK) and on pain-related self-efficacy (Chronic Disease Self-Efficacy Scale short version - CDSES-6). Finally, participants will be randomly assigned to one of three intervention programs: 1) Thermal care group, 2) Thermal care + Exercises group, and 3) Control group. Immediately after group assignment (same session), participants will meet a physical therapist (PT) to review their assigned program (60-minutes meeting), during which a ThermaCare® Heat wrap or a sham wrap will be applied by the PT. In Thermal Care + Exercises group, an exercise program will be taught by the PT then performed by participants. General advices on the management of acute LBP will be given to all participants. Thereafter, the immediate effect of thermal therapy on pain will be evaluated (1-hour post-intervention assesment).
After the baseline evaluation and PT session, participants will perform their assigned 7-day intervention program. Every day, they will complete a logbook related to their pain level during the previous day and to their adherence to their program. In addition, participants will wear a fitness wristband to track physical activity level for 7 days (number of steps per day). Then, pain, ODI, GRC, TSK and CDSES-6 will be assessed at 1 week, 1 month, 3 months and 6 months after baseline to determine short-, middle-, and long-term effect of interventions.
Randomisation: a list will be generated using a computer random number generator by an independent research assistant (allocation concealed in sealed and opaque envelopes).
Sample size & Statistical analyses: Based on sample size calculation, calculated for the primary outcome (ODI) and previous data from the project investigators group (n=50 with acute LBP), 20 participants are required per group (G*Power 3.1.7; effect size: 0.80, α = 0.05, β = 0.80, mean baseline ODI of 44.0 +/- 13.5, lost at follow-up = 10%). Thus, 60 participants with acute LBP will be recruited.
To determine the effect of interventions, two-way ANOVA (Group x Time) will be performed (after confirming normality and homogeneity of variance). Bonferroni adjustments for multiple comparisons will be used (posthoc), and effect sizes will be reported (η2).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Québec, Canada, G1M 2S8
- Centre interdisciplinaire de recherche en réadaptation et intégration sociale (CIRRIS)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- to be suffering from low back pain (LBP) for a period of less than 6 weeks (with or without leg pain) that had limited one's activities or changed the daily routine for more than a day,
- to have been pain free for at least 3 months before the onset of the current LBP episode.
Exclusion Criteria:
- "red flag" signs that may suggest serious spinal pathology,
- history of spinal surgery,
- obvious lower limb radiculopathy
- fibromyalgia
- rheumatoid arthritis
- important skin lesion in the lumbar area
- alteration of cutaneous sensations or temperature perception
- being pregnant of trying to become
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Thermal care
Participants will be asked to wear a heat wrap over the lower lumbar spine, during the day for 8 hours on 7 consecutive days.
The Thermal care group will also receive education by a physiotherapist on acute low back pain management.
|
Wearing of a light elastic lower back heating wrap, which heats up to 40°C within 30 minutes and maintains this temperature continuously for 8 hours.
Heat wrap will be worn during the day for 8 hours on 7 consecutive days.
Other Names:
Participants will receive education on the management of acute low back pain by a physiotherapist .
The main topics addressed will be patient reassurance, staying active, avoiding bed rest, activity modification, and sitting and bed postures/transfer.
Participants will received a document that details advices covered during the session and the physiotherapist will answer any questions.
|
Experimental: Thermal care + exercises
In addition to heat wrap and pain management education as for Thermal care group, participants of this group will be asked to perform exercises at home over 7 days, targeted on functional capacity, lumbar mobility, and slight contraction of trunk muscle (posture and/or cognitive).
|
Wearing of a light elastic lower back heating wrap, which heats up to 40°C within 30 minutes and maintains this temperature continuously for 8 hours.
Heat wrap will be worn during the day for 8 hours on 7 consecutive days.
Other Names:
Participants will receive education on the management of acute low back pain by a physiotherapist .
The main topics addressed will be patient reassurance, staying active, avoiding bed rest, activity modification, and sitting and bed postures/transfer.
Participants will received a document that details advices covered during the session and the physiotherapist will answer any questions.
In addition of exercises performed with the physiotherapist at the first session, exercises will be performed at home five times over the next 7 days, for approximately 30 minutes each performing day.
Three different categories of exercises will be given: 1) Functional activities exposure (sitting, sit-to-stand, lifting, bending, etc.); 2) cognitive contraction of trunk muscles and basic trunk motor control exercises; 3) mobility of the lumbar spine and preferential direction of movement.
Exercises will be chosen and adapted for each participant by a physiotherapist, in function of pain presentation and intensity, and response to exercises.
|
Sham Comparator: Control
Participants in the control group will receive the same education program as those of the two other groups.
A sham non-heating wrap will be used to control for potential supportive and sensory influence of the heat wrap.
|
Participants will receive education on the management of acute low back pain by a physiotherapist .
The main topics addressed will be patient reassurance, staying active, avoiding bed rest, activity modification, and sitting and bed postures/transfer.
Participants will received a document that details advices covered during the session and the physiotherapist will answer any questions.
The same lower back wrap as the Thermal care group will be used, but cooled down to room temperature (opened in advance).
The wrap will be worn following the same parameters (duration, frequency) than the Thermal care group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in functional limitations and symptoms measured with the Oswestry Disability Index (ODI) version 2.1
Time Frame: Change from baseline at 1-week, 1-month, 3-month and 6-month follow-up
|
A list of ten items to assess symptoms (low back pain) and the functional disability it has caused in 9 different areas of everyday life.
Score ranges from 0 to 100.
|
Change from baseline at 1-week, 1-month, 3-month and 6-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Immediate change in current pain intensity after a 1-hour intervention with a numerical rating scale.
Time Frame: Change from baseline to 1 hour (after a 1-hour intervention)
|
11-points rating scale (0 to 10), ranging from ''No pain'' to ''Worst pain imaginable''
|
Change from baseline to 1 hour (after a 1-hour intervention)
|
Change in ''average pain intensity during the last 24 hours'' at 1 week measured with a numerical rating scale.
Time Frame: Change between baseline and after the 1-week intervention
|
11-points rating scale (0 to 10), ranging from ''No pain'' to ''Worst pain imaginable''
|
Change between baseline and after the 1-week intervention
|
Change in ''average pain intensity during the last 7 days'' measured with a numerical rating scale.
Time Frame: Change from baseline at 1-month, 3-month and 6-month follow-ups
|
11-points rating scale (0 to 10), ranging from ''No pain'' to ''Worst pain imaginable''
|
Change from baseline at 1-month, 3-month and 6-month follow-ups
|
Change in pain-related fear measured with Tampa Scale of kinesiophobia (TSK-11).
Time Frame: Change from baseline at 1-week, 1-month, 3-month and 6-month follow-up
|
11-item version of the TSK questionnaire that measures problematic beliefs and behaviours associated with pain, focusing on beliefs that pain is damaging and that painful movements should be avoided.
Each item is rated on a 4-point Likert scale (1=strongly disagree, 4=strongly agree).
The total score ranges from 11 to 44 points, and higher scores signify greater fear of re-injury due to movement.
|
Change from baseline at 1-week, 1-month, 3-month and 6-month follow-up
|
Change in self-efficacy measured with the Chronic Disease Self-Efficacy Scale - Short-Version (CDSES-6)
Time Frame: Change from baseline at 1-week, 1-month, 3-month and 6-month follow-up
|
6-item version of the CDSES-33 questionnaire which measures the self-efficacy to perform behaviors and to achieve outcomes among those with chronic diseases (also validated with chronic pain for French Canadian population).
Each item is measured using a numerical scale ranging from 1 (not at all confident) to 10 (totally confident).
The total score is obtained by calculating the mean of the 6 items and ranges from 1 to 10. Higher scores indicate higher self-efficacy.
|
Change from baseline at 1-week, 1-month, 3-month and 6-month follow-up
|
Change in physical activity level at 1 week, assessed by the number of steps walked per day.
Time Frame: Difference between groups at 1 week
|
Measured with a fitness wristband
|
Difference between groups at 1 week
|
Global Rating of Change
Time Frame: Collected at 1-week, 1-month, 3-month and 6-month follow-up
|
A single-item question that asks whether and to what extent the patient perceive change in his global lower back pain condition has occurred, since the initial evaluation, on a 15-point Likert scale
|
Collected at 1-week, 1-month, 3-month and 6-month follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Hugo Massé-Alarie, Laval University, Quebec City
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Heat and exercises for ALBP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Ache Laboratorios Farmaceuticos S.A.Unknown
-
Palmer College of ChiropracticDepartment of Health and Human ServicesCompletedChronic Low Back Pain | Subacute Low Back PainUnited States
-
Universität Duisburg-EssenSiemens-BetriebskrankenkasseCompletedChronic Low Back Pain | Recurrent Low Back Pain
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Apsen Farmaceutica S.A.CompletedLow Back Pain | Low Back Pain, Mechanical | Acute Low Back PainBrazil
Clinical Trials on Thermal care
-
Johns Hopkins Bloomberg School of Public HealthTerminated
-
Fatma ÖzkalNecmettin Erbakan UniversityCompleted
-
International Centre for Diarrhoeal Disease Research...Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh; Directorate... and other collaboratorsRecruiting
-
Istituti Clinici Scientifici Maugeri SpACompleted
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnStage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | Invasive Ductal Breast CarcinomaUnited States
-
Chattem, Inc.TerminatedHealthyUnited States
-
Swiss Group for Clinical Cancer ResearchImmunophotonics, Inc.RecruitingAdvanced Solid TumorsSwitzerland
-
Hsin-Wen HsuKaohsiung Medical University Chung-Ho Memorial HospitalCompleted
-
M.D. Anderson Cancer CenterBioTex, Inc.Terminated
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Copenhagen Trial Unit, Center for Clinical Intervention...CompletedExperimental Pain in Healthy MalesDenmark